Journal Article

Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses

Binshtein, Elad, Stass, Robert, Reidy, Joseph X., Hulswit, Ruben J. G., Engdahl, Taylor B., Chapman, Nathaniel S., Westover, Jonna L. B., Paesen, Guido C., Gowen, Brian B., Bowden, Thomas A., Flores, Alejandra, Crowe, James E., Handal, Laura S.

2023

Overview

The zoonotic Rift Valley fever virus (RVFV) can cause severe disease in humans and has pandemic potential, yet no approved vaccine or therapy exists. Here we describe a dual-mechanism human monoclonal antibody (mAb) combination against RVFV that is effective at minimal doses in a lethal mouse model of infection. We structurally analyze and characterize the binding mode of a prototypical potent Gn domain-A-binding antibody that blocks attachment and of an antibody that inhibits infection by abrogating the fusion process as previously determined. Surprisingly, the Gn domain-A antibody does not directly block RVFV Gn interaction with the host receptor low density lipoprotein receptor-related protein 1 (LRP1) as determined by a competitive assay. This study identifies a rationally designed combination of human mAbs deserving of future investigation for use in humans against RVFV infection. Using a two-pronged mechanistic approach, we demonstrate the potent efficacy of a rationally designed combination mAb therapeutic. There are currently no treatment options for infection with Rift Valley fever virus (RVFV). Here, Chapman et al., show that a combination of human monoclonal antibodies targeting two different steps in early virus cell entry enhances protection in a mouse model and is effective at low doses.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 101/28 / 45/23 / 631/250/255/2514 / 631/326/22/1295 / 631/535/1266 / 64 / 64/60 / 82/1 / 82/83 / Animals / Antibodies, Monoclonal / Binding / Biological Assay / Coccidioidomycosis / Disease Models, Animal / Fever / Humanities and Social Sciences / Humans / Infections / Low density lipoprotein / Low Density Lipoprotein Receptor-Related Protein-1 / Low density lipoprotein receptors / Mice / Monoclonal antibodies / multidisciplinary / Pandemics / Receptor density / Receptors / Rift Valley fever / Rift Valley fever virus / Science / Science (multidisciplinary) / Vector-borne diseases / Viral diseases / Viruses / Zoonoses